SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Chemical Name: (4aS,4bS,6S,10aS,10bR,11S,12aS)-10b-Fluoro-1,11-dihydroxy-1,6,10a,12a-tetramethyl-1,3,4,4a,4b,5,6,10a,10b,11,12,12a-dodecahydrochrysene-2,8-dione
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Smiles: O=C(CC[C@@]1([H])[C@]2([H])C[C@H](C)C3=C4)C(C)(O)[C@@]1(C)C[C@H](O)[C@]2(F)[C@@]3(C)C=CC4=O
Fluorometholone D Homo Derivative is chemically (4aS,4bS,6S,10aS,10bR,11S,12aS)-10b-Fluoro-1,11-dihydroxy-1,6,10a,12a-tetramethyl-1,3,4,4a,4b,5,6,10a,10b,11,12,12a-dodecahydrochrysene-2,8-dione. Fluorometholone D Homo Derivative is supplied with detailed characterization data compliant with regulatory guideline. Fluorometholone D Homo Derivative can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fluorometholone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Validated HPTLC and HPLC methods for determination of fluorometholone and sodium cromoglycate in presence of their impurities and degradation products; application to kinetic study and on rabbit aqueous humor
Maha A. Hegazy, May H. Abdelwahab, Hassan A. M. Hendawy, Soheir A. Weshahy & Samah S. Abbas
Journal of Liquid Chromatography & Related Technologies Volume 41, 2018 - Issue 5 Pages 203-222
Hplc method for determination of fluorometholone and sodium cromoglycate in bulk and ophthalmic solution
Hani M. Hafez, Abdulla A. Elshanawany, Lobna M. Abdelaziz, Mustafa S. Mohram
J App Pharm Vol. 7; Issue 1: 01-08; January, 2015